Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...

People with central vision loss can judge the motion of vehicles almost as accurately as people with normal vision, a new ...

In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...

The recent proposal by four of the country’s most influential business and governance groups—the Institute of Corporate Directors (ICD), the Institute for Solidarity in Asia (ISA), the Justice Reform ...

In the first long-term and real-world reflective study of its kind, scientists have uncovered new detrimental health impacts of the artificial sweetener aspartame that echoes those found in shorter ...

Trump Media & Technology Group, the social media and crypto company part owned by President Trump, said it would help develop ...

Trump Media & Technology Group, the parent company of President Donald Trump's Truth Social platform, announced a merger ...

Neutrophils cause time-of-day–dependent collateral tissue damage after sterile injury through an intrinsic circadian program.

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...

A study led by IGTP researchers shows that, in a laboratory model, delafloxacin inhibits the intracellular replication ...